Craig Adeyanju

InvestorPlace Contributor

Craig Adeyanju enjoys to unearth awesome growth and value stocks and educate investors about the companies behind them. He believes that the best companies to invest in are those that genuinely solve a problem.

His work has appeared on sites like TheStreet, The Motley Fool, Benzinga among others.

Recent Articles

ABBV Stock: Could AbbVie Inc’s Gamble on Stemcentrx Pay Off?

By Craig Adeyanju, InvestorPlace Contributor

Stemcentrx's acquisition does little to alleviate the risk of the potential decrease in sales once Humira loses patent protection.

Apple Inc.: AAPL Is Losing Its High-End Mojo

By Craig Adeyanju, InvestorPlace Contributor

If Apple can’t find a way to regain its innovative edge and grow the high-end market, AAPL stock will eventually have to target the mass market for growth.

Valeant Pharmaceuticals Intl Inc: Is VRX Stock a Dip-Buying Opportunity?

By Craig Adeyanju, InvestorPlace Contributor

VRX might have finally filed its overdue annual report, but Valeant still faces a long road to recovery.

Sirius XM Holdings Inc. (SIRI): The One Number That Matters

By Craig Adeyanju, InvestorPlace Contributor

Since economical connected cars should become more popular in future, SIRI might become less profitable, as those drivers are less likely to subscribe to Sirius.

McDonald’s Corporation (MCD) Remains on the Road to Recovery

By Craig Adeyanju, InvestorPlace Contributor

MCD has just posted its third consecutive quarter of comparable store sales. It seems a McDonald's recovery is truly on.

Load More